The Indian government has declined the requests of U.S. companies and COVID vaccine manufacturers Pfizer & Moderna for legal protection over any side effects from the use of their shots.

This information came along with India’s September 2021 announcement that they will not buy COVID-19 shots from Pfizer/BioNTech and Moderna. It was reported that the main reason for this was because domestic output of more affordable, and easier to store, vaccines climbed.

Newly released Pfizer documents revealed tens of thousands of adverse reactions reported in the first two months of 2021 and shows that they were well aware of this issue.

By October 15th, 2021, worldwide vaccine injury reports for COVID vaccines passed 2,344,240 according to World Health Organization (WHO) reporting system, VigiAccess.

More than 50 percent of vaccine injuries reported to the CDC’s Vaccine Adverse Events Reporting System (VAERS) are from COVID shots. Perhaps more concerning is the fact that experts estimate that only about 1 percent of vaccine injuries are even reported.

This level of underreporting may come as a shock, but it shouldn’t. Adverse reactions to drugs have always been severely underreported, this is well known and it represents a big problem in medicine.

Pfizer and Moderna trying to gain freedom from legal liability in India is no surprise. What is surprising is that the Indian government denied this request when vaccine manufacturers are already liability free in multiple countries like the US & Canada.

Indemnifying vaccine makers from liability has been a common theme throughout this pandemic. It allows manufacturers to get their products on the market faster, but it’s also a troublesome thought that there is no legal incentives for these companies to to create safe vaccines and really vet their product.